Nisa Investment Advisors, LLC Gilead Sciences, Inc. Transaction History

Nisa Investment Advisors, LLC

$15.2 Billion
Q1 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 347,424 shares of GILD stock, worth $23.8 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

347,424

Previous 393,792 11.77%

Holding current value

$23.8 Million

Previous $31.9 Million 20.23%

% of portfolio

0.17%

Previous 0.23%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$71.58 - $87.29 $3.32 Million - $4.05 Million	-46,368 Reduced 11.77%	347,424 $25.4 Million
Q4 2023 Jan 25, 2024	SELL	$73.27 - $83.09 $670,567 - $760,439	-9,152 Reduced 2.27%	393,792 $31.9 Million
Q3 2023 Nov 02, 2023	BUY	$73.94 - $80.67 $816,371 - $890,677	11,041 Added 2.82%	402,944 $30.2 Million
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $1.24 Million - $1.42 Million	-16,359 Reduced 4.01%	391,903 $30.2 Million
Q1 2023 May 02, 2023	BUY	$77.31 - $88.08 $2.2 Million - $2.51 Million	28,494 Added 7.5%	408,262 $33.9 Million

Q4 2022 Feb 02, 2023	SELL	$62.32 - $89.47 $946,765 - $1.36 Million	-15,192 Reduced 3.85%	379,768 $32.6 Million
Q3 2022 Nov 07, 2022	BUY	$59.54 - $68.01 $1.04 Million - $1.19 Million	17,440 Added 4.62%	394,960 $24.5 Million
Q2 2022 Aug 03, 2022	BUY	$57.72 - $65.01 $1.03 Million - $1.16 Million	17,800 Added 4.95%	377,520 $23.3 Million
Q1 2022 Apr 29, 2022	SELL	$57.92 - $72.58 $6.31 Million - $7.9 Million	-108,911 Reduced 23.24%	359,720 $21.4 Million
Q4 2021 Feb 03, 2022	SELL	$64.88 - $73.64 $820,083 - $930,809	-12,640 Reduced 2.63%	468,631 $32.2 Million
Q3 2021 Oct 18, 2021	SELL	$67.69 - $73.03 $1.71 Million - $1.85 Million	-25,335 Reduced 5.0%	481,271 $33.6 Million
Q2 2021 Aug 06, 2021	SELL	$63.47 - $69.35 $4.26 Million - $4.65 Million	-67,093 Reduced 11.69%	506,606 $34.9 Million
Q1 2021 Apr 26, 2021	SELL	$60.0 - $68.46 $949,140 - $1.08 Million	-15,819 Reduced 2.68%	573,699 $37.1 Million
Q4 2020 Jan 25, 2021	BUY	$56.65 - $64.55 $1.16 Million - $1.33 Million	20,563 Added 3.61%	589,518 $34.3 Million
Q3 2020 Oct 20, 2020	SELL	$62.1 - $78.08 $3.65 Million - $4.58 Million	-58,721 Reduced 9.36%	568,955 $36 Million
Q2 2020 Jul 27, 2020	BUY	$72.34 - $84.0 $9 Million - $10.4 Million	124,364 Added 24.71%	627,676 $48.3 Million
Q1 2020 Apr 17, 2020	SELL	$62.63 - $80.22 $501,666 - $642,562	-8,010 Reduced 1.57%	503,312 $37.6 Million
Q4 2019 Jan 17, 2020	SELL	$61.62 - $67.78 $921,527 - $1.01 Million	-14,955 Reduced 2.84%	511,322 $33.2 Million
Q3 2019 Oct 17, 2019	BUY	$62.51 - $69.0 $1.13 Million - $1.24 Million	18,038 Added 3.55%	526,277 $33.4 Million
Q2 2019 Jul 12, 2019	BUY	$61.87 - $69.38 $99,177 - $111,216	1,603 Added 0.32%	508,239 $34.3 Million
Q1 2019 Apr 17, 2019	SELL	$62.53 - $70.05 $836,338 - $936,918	-13,375 Reduced 2.57%	506,636 $32.9 Million
Q4 2018 Jan 17, 2019	BUY	$60.54 - $79.0 $833,635 - $1.09 Million	13,770 Added 2.72%	520,011 $32.5 Million
Q3 2018 Oct 16, 2018	BUY	$71.28 - $78.92 $374,220 - $414,330	5,250 Added 1.05%	506,241 $39.1 Million
Q2 2018 Jul 19, 2018	SELL	$64.88 - $75.68 $2.65 Million - $3.09 Million	-40,862 Reduced 7.54%	500,991 $35.5 Million
Q1 2018 Apr 10, 2018	SELL	$72.84 - $88.8 $378,768 - $461,760	-5,200 Reduced 0.95%	541,853 $41.2 Million
Q4 2017 Jan 12, 2018	BUY	$71.15 - $83.52 $405,199 - $475,646	5,695 Added 1.05%	547,053 $39.2 Million
Q3 2017 Oct 13, 2017	BUY	$72.11 - $85.47 $39 Million - $46.3 Million	541,358	541,358 $43.9 Million

Others Institutions Holding GILD

# of Institutions

1,884

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $86B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Gilead Sciences, Inc. Transaction History